| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP1513531A1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 03/16/2005 | EP1513530A1 Tetrahydroquinolines for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 03/16/2005 | EP1146873B1 Anti-androgens and methods for treating disease |
| 03/16/2005 | EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 03/16/2005 | EP0874625B1 Indane derivatives for antipsychotic compositions |
| 03/16/2005 | CN1594328A Olefin monomers of multi-functional group 8-hydroxyquinoline metal complex and their preparation process and application |
| 03/16/2005 | CN1594327A Olefin monomer of multi-functional group 8-hydroxyquinoline metal complex and its preparation process and application |
| 03/16/2005 | CN1594320A Process for preparing L-ofloxacin and ofloxacin |
| 03/16/2005 | CN1594295A Quinolinone compounds and preparing process and intermediate thereof |
| 03/16/2005 | CN1193028C Dual molecules containing peroxide derivative; synthesis and therapeutic applications thereof |
| 03/16/2005 | CN1193017C Rice blast control agents |
| 03/16/2005 | CN1193016C Process for synthesizing inhibitor of phosphatidase A2 |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867219 Antitumor agents |
| 03/15/2005 | US6867218 An arylene or heteroarylene alkoxy or hydroxy-propionic acid or ester derivatives; treatment or prevention of Peroxisome Proliferator-Activated Receptors; diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 03/15/2005 | US6867217 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 03/15/2005 | CA2086914C Quinolone-and naphthyridone-carboxylic acid derivatives |
| 03/11/2005 | WO2005103048A1 Quinolone carboxylic acid derivatives, thereof preparation and usage |
| 03/10/2005 | WO2005021553A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | WO2005021536A2 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors |
| 03/10/2005 | WO2005021530A1 8- (1-piperazinyl)- quinoline derivatives and their use in the treatment of cns disorders |
| 03/10/2005 | WO2005021509A1 Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2005000109A3 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 03/10/2005 | WO2004041802A8 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 03/10/2005 | US20050054853 Reacting 1,3-bis(trimethylsilyloxy)-1-alkoxybuta-1,3-diene with (E)-3-[2-cyclopropyl-4-(4-fluorophenyl)-quinolin-3-yl]-prop-2-en-1-al in presence of optical active binaphthol-titanium complex of a 1,1'-bi-2-naphthol, titanium tetraisopropoxide, metal salt and an amine; desilylation of reaction product |
| 03/10/2005 | US20050054690 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 03/10/2005 | US20050054675 Interferon $g(g) production promoter |
| 03/10/2005 | US20050054668 Antagonists of MCP-1 function and methods of use thereof |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | US20050054637 Prophylaxis, therapy cardiovascular disorders |
| 03/10/2005 | CA2537123A1 New compounds |
| 03/10/2005 | CA2536788A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1511732A1 Process for the manufacture of quinoline derivatives |
| 03/09/2005 | EP1511704A1 Polymerisation inhibitor |
| 03/09/2005 | EP1511395A1 Method of extracting rutin from buck wheat growed by hydroponics |
| 03/09/2005 | EP1345892B1 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 03/09/2005 | CN1592745A Therapeutic chromone compounds |
| 03/09/2005 | CN1592741A Antiretroviral pyridine and quinoline derivatives |
| 03/09/2005 | CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 03/09/2005 | CN1592623A Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity |
| 03/09/2005 | CN1590377A Process for preparing aripiprazole |
| 03/09/2005 | CN1590376A Now preparation method of alipazole |
| 03/09/2005 | CN1590375A TNF-alpha prodn. inhibitors |
| 03/09/2005 | CN1590374A TNF-alpha prodn. inhibitors |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/09/2005 | CN1192015C Cell adhesion inhibitors |
| 03/08/2005 | US6864392 α-Sulfin and α-Sulfonamino amide derivatives |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/03/2005 | WO2005019240A2 Melanin concentrating hormone receptor antagonists |
| 03/03/2005 | WO2005019201A2 Process for the preparation of 4-amino-3-quinolinecarbonitriles |
| 03/03/2005 | WO2005019178A1 Reagent resistance stabiliser for nitro-cellulose propellants and solid rocket propellant and method for treatment thereof |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005018573A2 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| 03/03/2005 | WO2005018557A2 Substituted pyridinones |
| 03/03/2005 | WO2005018529A2 Phenoxiacetic acid derivatives |
| 03/03/2005 | US20050049413 Quinoline derivatives |
| 03/03/2005 | US20050049274 Selective, potent small molecule protein tyrosine kinase inhibitors; such as 6-chloro-3-(3-methyl-isoxazol-5-yl)-4-(pyridin-4-yl)-1H-quinolin-2-one |
| 03/03/2005 | US20050049264 Suppressing growth of abnormal cells; gastric, brain, colon, pancreatic, lung, renal, ovarian and prostatic cancer |
| 03/03/2005 | US20050049252 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 03/03/2005 | US20050049238 Heterocyclic retinoid compounds |
| 03/03/2005 | CA2536349A1 6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds |
| 03/03/2005 | CA2535714A1 Phenoxyacetic acid derivatives |
| 03/03/2005 | CA2535385A1 Process for the preparation of 4-amino-3-quinolinecarbonitriles |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1509516A1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
| 03/02/2005 | EP1509218A1 Peptide deformylase inhibitors |
| 03/02/2005 | EP0876347B1 Quinoline derivatives |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589307A Phosphorescent compounds and devices comprising the same |
| 03/02/2005 | CN1589264A Method for the treatment of malignant tumours |
| 03/02/2005 | CN1589263A Process for producing optically active oxoheptenoic acid ester |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1191339C Lubricating compositions cintaining aromatized 1,2-dihydro-2,2,4-trimethylquinoline polymers |
| 03/02/2005 | CN1191248C 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype lignds |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/01/2005 | US6861528 Carboxylated heterocyclic compounds and methods of synthesis |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 02/24/2005 | WO2005017185A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS |
| 02/24/2005 | WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 02/24/2005 | WO2005016888A1 Probe for diseases wth amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 02/24/2005 | WO2005016886A1 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016384A1 Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | WO2004078730A3 Method for producing optically active amines |
| 02/24/2005 | US20050043544 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 02/24/2005 | US20050043537 Amidation of cyanoacetic acid with an acid catalyst, condensation of the cyanoacetamide with aniline, an alcohol solvent, and a trialkylorthoformate, cyclization of the 3-amino-2-cyanoacrylamide; mild conditions; protein kinase inhibitors |
| 02/24/2005 | US20050043358 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |
| 02/24/2005 | US20050043341 For stimulation of reverse cholesterol transport, lowering low density lipoproteins in blood; for treatment of hypolipoproteinaemia, dyslipidaemias, hypertriglyceridaemias, hyperlipidaemias, arteriosclerosis adiposity and obesity stroke or Alzheimer's disease |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |